What Researchers Did
Researchers reviewed advances in the diagnosis and treatment of necrotizing external otitis over the past 20 years.
What They Found
Advances over the past 20 years, including hyperbaric oxygen therapy and new antibiotics, substantially improved the prognosis of necrotizing external otitis (NEO). Radioisotope examination facilitates diagnosis and indicates treatment termination, with medical treatment preferred over surgery for most patients. Consequently, NEO is no longer considered "malignant" for the majority of patients when diagnosed in time and treated adequately.
What This Means for Canadian Patients
Canadian patients with necrotizing external otitis may benefit from modern diagnostic tools and a combination of advanced antibiotic therapies, potentially including hyperbaric oxygen. Early diagnosis and appropriate medical management are crucial for improving outcomes and reducing the severity of this condition.
Canadian Relevance
This study, published in a Czech journal in 1989, has no direct Canadian connection.
Study Limitations
The abstract does not describe a specific study design or provide patient numbers, limiting the ability to assess the strength of evidence for the discussed treatment advances.